Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aod 9604
2. Aod-9604
3. Aod9604
4. Somatostatin (177-191), Tyr-
5. Somatostatin (177-191), Tyrosyl-
6. Tyr-somatostatin (177-191)
1. Aod 9604
2. 221231-10-3
3. Aod-9604
4. 7up768ip4m
5. Aod9604
6. Ex-a4625
7. L-phenylalanine, L-tyrosyl-l-leucyl-l-arginyl-l-isoleucyl-l-valyl-l-glutaminyl-l-cysteinyl-l-arginyl-l-seryl-l-valyl-l-.alpha.-glutamylglycyl-l-seryl-l-cysteinylglycyl-, Cyclic (7->14)-disulfide
8. Tyr-leu-arg-ile-val-gln-cys-arg-ser-val-glu-gly-ser-cys-gly-phe Cyclic (7->14)-disulfide
| Molecular Weight | 1815.1 g/mol |
|---|---|
| Molecular Formula | C78H123N23O23S2 |
| XLogP3 | -4.8 |
| Hydrogen Bond Donor Count | 28 |
| Hydrogen Bond Acceptor Count | 28 |
| Rotatable Bond Count | 45 |
| Exact Mass | 1813.86035961 g/mol |
| Monoisotopic Mass | 1813.86035961 g/mol |
| Topological Polar Surface Area | 815 Ų |
| Heavy Atom Count | 126 |
| Formal Charge | 0 |
| Complexity | 3710 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 15 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A AOD 9604 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AOD 9604, including repackagers and relabelers. The FDA regulates AOD 9604 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AOD 9604 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AOD 9604 supplier is an individual or a company that provides AOD 9604 active pharmaceutical ingredient (API) or AOD 9604 finished formulations upon request. The AOD 9604 suppliers may include AOD 9604 API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AOD 9604 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AOD 9604 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AOD 9604 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AOD 9604 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AOD 9604 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AOD 9604 suppliers with NDC on PharmaCompass.
AOD 9604 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AOD 9604 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AOD 9604 GMP manufacturer or AOD 9604 GMP API supplier for your needs.
A AOD 9604 CoA (Certificate of Analysis) is a formal document that attests to AOD 9604's compliance with AOD 9604 specifications and serves as a tool for batch-level quality control.
AOD 9604 CoA mostly includes findings from lab analyses of a specific batch. For each AOD 9604 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AOD 9604 may be tested according to a variety of international standards, such as European Pharmacopoeia (AOD 9604 EP), AOD 9604 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AOD 9604 USP).
LOOKING FOR A SUPPLIER?
